العربية Join the community
← Back to all jobs
Mercor

Biotech Investment Analyst — Drug Asset & Company Assessment

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development…

Description as posted by Mercor:

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

Responsibilities

  • Create and critique rubrics that analyze commercial drugs and drug-development programs
  • Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
  • Apply your assessment across the pilot's set of companies (~5–10)

Requirements

  • US-based biotech / healthcare investment analyst with a specialist-fund background
  • Familiarity with biotech/pharma development programs
  • Able to assess a drug asset and the company behind it end-to-end
  • 5+ years evaluating biotech/pharma companies or assets

Engagement Details

  • Duration: Approximately 10–20 hours over a 1–2 week pilot
  • Remote — US-based

Why Participate

  • Help improve expert AI evaluation of drugs and drug-development programs
  • Recurring engagement for strong contributors

About Mercor

Mercor connects experienced professionals with AI labs that need people to evaluate, write and correct model output, in fields from medicine and law to software and languages.

How applying works: You apply with your CV, then take a short AI-led interview whenever it suits you.

All Mercor jobs →